Lamdong Pharmaceutical Joint Stock Company
Lamdong Pharmaceutical Joint Stock Company, commonly known as Ladophar, is a prominent player in the pharmaceutical industry, headquartered in Lam Dong Province, Vietnam. Established in 1983, the company has made significant strides in the production and distribution of high-quality pharmaceutical products, primarily focusing on generic medicines, herbal remedies, and dietary supplements. With a strong operational presence across Vietnam, Ladophar is recognised for its commitment to innovation and quality. The company’s core offerings include a diverse range of pharmaceuticals that cater to various therapeutic areas, setting them apart through rigorous quality control and adherence to international standards. Ladophar has achieved notable milestones, including certifications from global health authorities, which solidify its market position as a trusted provider in the Vietnamese pharmaceutical landscape.
DitchCarbon Score
How does Lamdong Pharmaceutical Joint Stock Company's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Lamdong Pharmaceutical Joint Stock Company's score of 10 is lower than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Lamdong Pharmaceutical Joint Stock Company's reported carbon emissions
Lamdong Pharmaceutical Joint Stock Company, headquartered in Vietnam, currently does not have available data on carbon emissions, as no specific emissions figures have been reported. Consequently, there are no documented reduction targets or climate commitments outlined by the company. In the absence of concrete emissions data, it is essential to note that many companies in the pharmaceutical sector are increasingly focusing on sustainability and climate action, often setting ambitious targets to reduce their carbon footprint. However, without specific commitments or initiatives from Lamdong Pharmaceutical, it is unclear how they align with industry standards for climate responsibility.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Lamdong Pharmaceutical Joint Stock Company is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
